James William Kupiec - Aug 23, 2022 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role: Chief Clinical Dev. Officer
Signature: /s/JAMES KUPIEC
Stock symbol: SAVA
Transactions as of: Aug 23, 2022
Transactions value $: $61,100
Form type: 4
Date filed: 8/24/2022, 04:02 PM
Next filing: Oct 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAVA	Common Stock	Purchase	$61.1K	+2.5K		$24.44	2.5K	Aug 23, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.

Content

The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.